246 related articles for article (PubMed ID: 25743304)
1. [The role of SGLT-2 inhibitors in the treatment of type 2 diabetes].
Rupprecht H
MMW Fortschr Med; 2015 Jan; 157(1):55-8. PubMed ID: 25743304
[No Abstract] [Full Text] [Related]
2. Combinational therapy with metformin and sodium-glucose cotransporter inhibitors in management of type 2 diabetes: systematic review and meta-analyses.
Zhang Q; Dou J; Lu J
Diabetes Res Clin Pract; 2014 Sep; 105(3):313-21. PubMed ID: 25015317
[TBL] [Abstract][Full Text] [Related]
3. Sodium glucose transporter 2 inhibition: a new approach to diabetes treatment.
Bloomgarden Z
J Diabetes; 2013 Sep; 5(3):225-7. PubMed ID: 23714218
[No Abstract] [Full Text] [Related]
4. SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.
Shyangdan DS; Uthman OA; Waugh N
BMJ Open; 2016 Feb; 6(2):e009417. PubMed ID: 26911584
[TBL] [Abstract][Full Text] [Related]
5. [SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes].
Seufert J
Dtsch Med Wochenschr; 2014 Feb; 139 Suppl 2():S52-8. PubMed ID: 24481633
[No Abstract] [Full Text] [Related]
6. Ketonuria/ketonemia associated with the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in type 2 diabetes: A report of three cases from New Delhi, India.
Ghosh A; Gupta R; Misra A
J Diabetes; 2016 Sep; 8(5):738-9. PubMed ID: 27085074
[No Abstract] [Full Text] [Related]
7. [Canagliflozin monotherapy: clinical study data in type 2 diabetes mellitus].
Matthaei S
Dtsch Med Wochenschr; 2014 Feb; 139 Suppl 2():S59-64. PubMed ID: 24481634
[No Abstract] [Full Text] [Related]
8. What is the place of new SGLT-2 inhibitors in therapy and on the formulary?
Mehr SR; Zimmerman MP
Am J Manag Care; 2014 Mar; 20(4 Spec No.):E1. PubMed ID: 25618509
[No Abstract] [Full Text] [Related]
9. The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.
Lajara R
Expert Opin Pharmacother; 2014 Dec; 15(17):2565-85. PubMed ID: 25316597
[TBL] [Abstract][Full Text] [Related]
10. [SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!].
Nauck M; Del Prato S
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S4-5. PubMed ID: 23529569
[No Abstract] [Full Text] [Related]
11. [Introduction].
García SD
Med Clin (Barc); 2013 Sep; 141 Suppl 2():1-2. PubMed ID: 24444516
[No Abstract] [Full Text] [Related]
12. Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitus.
Mikhail N
South Med J; 2015 Feb; 108(2):91-6. PubMed ID: 25688893
[TBL] [Abstract][Full Text] [Related]
13. Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea.
Ji L; Han P; Liu Y; Yang G; Dieu Van NK; Vijapurkar U; Qiu R; Meininger G
Diabetes Obes Metab; 2015 Jan; 17(1):23-31. PubMed ID: 25175734
[TBL] [Abstract][Full Text] [Related]
14. Can we go beyond surrogates?
Drexler A
J Diabetes; 2017 Nov; 9(11):976-977. PubMed ID: 28692750
[TBL] [Abstract][Full Text] [Related]
15. Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus.
Goldberg N; Fralick M
CMAJ; 2017 May; 189(20):E724. PubMed ID: 28536128
[No Abstract] [Full Text] [Related]
16. Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.
Sha S; Polidori D; Heise T; Natarajan J; Farrell K; Wang SS; Sica D; Rothenberg P; Plum-Mörschel L
Diabetes Obes Metab; 2014 Nov; 16(11):1087-95. PubMed ID: 24939043
[TBL] [Abstract][Full Text] [Related]
17. [Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes].
Røder ME; Storgaard H; Rungby J; Knop FK; Vilsbøll T
Ugeskr Laeger; 2016 Sep; 178(38):. PubMed ID: 27649712
[TBL] [Abstract][Full Text] [Related]
18. Increased grip strength with sodium-glucose cotransporter 2.
Sano M; Meguro S; Kawai T; Suzuki Y
J Diabetes; 2016 Sep; 8(5):736-7. PubMed ID: 27038414
[No Abstract] [Full Text] [Related]
19. [Positive experience with SGLT-2 inhibitor in general practice].
Fath R
MMW Fortschr Med; 2015 Jul; 157(13):83. PubMed ID: 26206058
[No Abstract] [Full Text] [Related]
20. [Glycosuria with SGLT-2 inhibitors--a new treatment approach for type 2 diabetes mellitus].
Rosak C; Forst T
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():95-101. PubMed ID: 23326927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
